Panel: From Commodity to Critical: Rethinking the Role of Pharmaceutical Ingredients
Day 2 Supply & Formulation Excellence Stage
07/10/2026 16:15 - 17:00pm
Contributors
Anita Vasilevska : Global Technical Marketing Manager - IMCD Group
Dejan Lamešić : Director of Product Development - Catalent
Francesco Giribaldi : Senior Account Consultant - ACS
Gyan Singh : Senior Vice President of Operations - Azurity Pharmaceuticals
Elizabeth Patrick : Partnership Development Manager - International Health Partners
As pharmaceutical formulations become more complex, ingredients are playing an increasingly critical role in drug performance, manufacturability, and supply security. This shift is forcing companies to move beyond traditional sourcing approaches and reassess how they engage with ingredient suppliers.
This closing panel brings together perspectives from across the value chain to explore how ingredient strategies are evolving. From closer supplier collaboration to increased internal control over critical materials, panellists will discuss how organisations can balance innovation, risk, and resilience in formulation development.